Medical Xpress
'Liquid gold' breast milk donations reduce life-threatening disease in premature babies by more than a third
Donated breast milk has cut cases of necrotizing enterocolitis — a deadly gut disease — by 38% in babies born before 32 weeks, according to new Australian research published in the Journal of Paediatrics and Child Health. The landmark study, the first of its kind in Australia, draws on donations supplied through Australian Red Cross Lifeblood. The findings make a compelling case for expanding donor milk programs as a frontline intervention in neonatal care.
Read article →Medical Xpress
Brain-body connection: Expert shares tips to reduce risk of cognitive decline, Alzheimer's disease
The habits that protect your heart and body do double duty for your brain. A cognitive neurologist at Mayo Clinic breaks down how lifestyle choices — from diet to exercise — directly lower the risk of Alzheimer's disease and cognitive decline. Early detection efforts are also advancing, making proactive brain health management more critical than ever.
Read article →Medical Xpress
Foundation fights medical errors that claim 200,000 US lives a year
Medical errors kill an estimated 200,000 Americans annually, making them one of the leading causes of preventable death in the country. One foundation is working to change that, advancing initiatives aimed at reducing mistakes across the healthcare system. The stakes are enormous — that death toll rivals or exceeds many of the diseases medicine works hardest to treat.
Read article →Guardian Health
DJ and broadcaster Paul Gambaccini reveals Alzheimer’s diagnosis
Paul Gambaccini, the 77-year-old broadcaster who has been a fixture on British radio and television since the 1970s, has publicly revealed an Alzheimer's diagnosis received earlier this year. The veteran presenter struck a measured tone in his statement, noting that life continues as normal for now and that he remains active on air. The disclosure from one of British broadcasting's most familiar voices will resonate widely across the industry and his long-standing audience.
Read article →Medical Xpress
First-in-human immunotherapy more than doubles progression-free survival in glioblastoma patients
A novel first-in-human immunotherapy has shown striking results against glioblastoma, more than doubling progression-free survival in patients with the deadliest form of adult brain cancer. The findings are significant given that standard treatment outcomes have barely shifted in 20 years, leaving patients with few meaningful options. This early-stage breakthrough signals a potential turning point in a disease long considered largely untreatable.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →